Stiefel clinical trials

Acquired by GlaxoSmithKline, Jul 22, 2009 · source ↗

The registry lists 56 studies whose lead sponsor is Stiefel. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 27, 2020.

Studies

Recruiting first, then most recently updated. Showing 50 of 56. List all 56 → · All GlaxoSmithKline studies →

• Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand EczemaCompletedNCT00817063Phase 3

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• Sexual Function in Men Receiving Dutasteride for Androgenetic AlopeciaCompletedNCT02014584Phase 3

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.CompletedNCT01323673Phase 4

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual OnychomycosisCompletedNCT00730405Phase 2

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis SubjectsCompletedNCT02673619Phase 2

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• Dose Ranging Study of the Safety and Efficacy of R115966 in Plaque PsoriasisCompletedNCT00716144Phase 2

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With AcneCompletedNCT01706263Phase 4

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• Efficacy of Alitretinoin Treatment in Patients With Pustular Form of PsoriasisCompletedNCT01245140Phase 2

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle FoamCompletedNCT00842153Phase 4

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITY™ II to PROACTIV™CompletedNCT01706250Phase 4

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne VulgarisCompletedNCT00757523Phase 4

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy VolunteersCompletedNCT01929278Phase 1

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne VulgarisCompletedNCT01019603Phase 1

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a CapsuleCompletedNCT01039883Phase 1

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• A Study of the Effects of Increasing Doses of a Drug for the Treatment of Nail FungusCompletedNCT01014962Phase 1

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy VolunteersCompletedNCT01115322Phase 1

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy VolunteersCompletedNCT01112787Phase 1

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy SubjectsCompletedNCT01984775Phase 1

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With AcneCompletedNCT01132443Phase 1

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy VolunteersCompletedNCT01114841Phase 1

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• A Study to Evaluate the Potential of Tazarotene Foam to Cause an Allergic Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers.CompletedNCT01119651Phase 1

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne MedicationsCompletedNCT00964366Phase 4

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne VulgarisCompletedNCT00160394Phase 4

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT GelCompletedNCT00689117Phase 3

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP)CompletedNCT00509275Phase 1

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial AcneCompletedNCT00841776Phase 4

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate AcneCompletedNCT00837213Phase 4

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With AcneCompletedNCT01446237Not applicable

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO WashCompletedNCT00891982Phase 3

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial AcneCompletedNCT01017120Phase 3

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 CreamCompletedNCT02411162Phase 1

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• 8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat AcneCompletedNCT02524665Phase 4

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical MedicationsCompletedNCT01015638Phase 4

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSACompletedNCT00852540Phase 3

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With AcneCompletedNCT00713609Phase 2

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.CompletedNCT00356915Phase 3

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2%CompletedNCT00703846Phase 4

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne VulgarisCompletedNCT01016977Phase 4

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body PsoriasisCompletedNCT01139580Phase 3

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301CompletedNCT01017146Phase 3

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 StudiesCompletedNCT00688519Phase 3

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of AcneCompletedNCT00887484Phase 4

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With AcneCompletedNCT00776919Phase 3

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial AcneCompletedNCT00964223Phase 4

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted after Stiefel became part of GlaxoSmithKline

• Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 StudiesCompletedNCT00689481Phase 3

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne MedicationsCompletedNCT00926367Phase 4

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type PsoriasisWithdrawnNCT00832364Phase 4

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand DermatitisCompletedNCT00828464Phase 4

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type PsoriasisCompletedNCT00852761Phase 4

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline

• Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and InfantsCompletedNCT00702507Phase 4

  Sponsor listed in the registry: Stiefel, a GSK Company · First submitted before Stiefel became part of GlaxoSmithKline